Search Results - "ST. CLAIR, MARTY"

Twenty-Five Years of Lamivudine: Current and Future Use for the Treatment of HIV-1 Infection by Quercia, Romina, Perno, Carlo-Federico, Koteff, Justin, Moore, Katy, McCoig, Cynthia, St. Clair, Marty, Kuritzkes, Daniel

“…ABSTRACTInnovation in medicine is a dynamic, complex, and continuous process that cannot be isolated to a single moment in time. Anniversaries offer…”
Get full text

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial by Margolis, David A, Gonzalez-Garcia, Juan, Stellbrink, Hans-Jürgen, Eron, Joseph J, Yazdanpanah, Yazdan, Podzamczer, Daniel, Lutz, Thomas, Angel, Jonathan B, Richmond, Gary J, Clotet, Bonaventura, Gutierrez, Felix, Sloan, Louis, Clair, Marty St, Murray, Miranda, Ford, Susan L, Mrus, Joseph, Patel, Parul, Crauwels, Herta, Griffith, Sandy K, Sutton, Kenneth C, Dorey, David, Smith, Kimberly Y, Williams, Peter E, Spreen, William R

“…Cabotegravir and rilpivirine are antiretroviral drugs in development as long-acting injectable formulations. The LATTE-2 study evaluated long-acting…”
Get full text

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection by Orkin, Chloe, Arasteh, Keikawus, Górgolas Hernández-Mora, Miguel, Pokrovsky, Vadim, Overton, Edgar T, Girard, Pierre-Marie, Oka, Shinichi, Walmsley, Sharon, Bettacchi, Chris, Brinson, Cynthia, Philibert, Patrick, Lombaard, Johan, St. Clair, Marty, Crauwels, Herta, Ford, Susan L, Patel, Parul, Chounta, Vasiliki, D’Amico, Ronald, Vanveggel, Simon, Dorey, David, Cutrell, Amy, Griffith, Sandy, Margolis, David A, Williams, Peter E, Parys, Wim, Smith, Kimberly Y, Spreen, William R

“…Simplified treatment regimens for HIV-1 may have advantages. In this open-label, randomized, controlled trial, patients with HIV-1 infection who had not…”
Get full text

Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis by Cutrell, Amy G., Schapiro, Jonathan M., Perno, Carlo F., Kuritzkes, Daniel R., Quercia, Romina, Patel, Parul, Polli, Joseph W., Dorey, David, Wang, Yongwei, Wu, Sterling, Van Eygen, Veerle, Crauwels, Herta, Ford, Susan L., Baker, Mark, Talarico, Christine L., Clair, Marty St, Jeffrey, Jerry, White, C. Thomas, Vanveggel, Simon, Vandermeulen, Kati, Margolis, David A., Aboud, Michael, Spreen, William R., van Lunzen, Jan

“…Efficacy and safety of long-acting cabotegravir (CAB) and rilpivirine (RPV) dosed intramuscularly every 4 or 8 weeks has been demonstrated in three Phase 3…”
Get full text

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials by Rizzardini, Giuliano, Overton, Edgar T., Orkin, Chloe, Swindells, Susan, Arasteh, Keikawus, Górgolas Hernández-Mora, Miguel, Pokrovsky, Vadim, Girard, Pierre-Marie, Oka, Shinichi, Andrade-Villanueva, Jaime F., Richmond, Gary J., Baumgarten, Axel, Masiá, Mar, Latiff, Gulam, Griffith, Sandy, Harrington, Conn M., Hudson, Krischan J., St. Clair, Marty, Talarico, Christine L., Patel, Parul, Cutrell, Amy, Van Eygen, Veerle, D'Amico, Ronald, Mrus, Joseph M., Wu, Sterling, Ford, Susan L., Chow, Ken, Roberts, Jeremy, Wills, Angela, Walters, Nicola, Vanveggel, Simon, Van Solingen-Ristea, Rodica, Crauwels, Herta, Smith, Kimberly Y., Spreen, William R., Margolis, David A.

“…Long-acting (LA) injectable regimens are a potential therapeutic option in people living with HIV-1. ATLAS (NCT02951052) and FLAIR (NCT02938520) were 2…”
Get full text

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine by Jeffrey, Jerry L, St Clair, Marty, Wang, Ping, Wang, Chunfu, Li, Zhufang, Beloor, Jagadish, Talarico, Christine, Fridell, Robert, Krystal, Mark, White, C Thomas, Griffith, Sandy, D'Amico, Ronald, Smith, Kimberly, Van Eygen, Veerle, Vingerhoets, Johan, Vandermeulen, Kati, Spreen, William, van Lunzen, Jan

“…The FLAIR study demonstrated noninferiority of monthly long-acting cabotegravir + rilpivirine versus daily oral dolutegravir/abacavir/lamivudine for…”
Get full text

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study by Smith, Graham H R, Henry, W Keith, Podzamczer, Daniel, Masiá, Maria Del Mar, Bettacchi, Christopher J, Arasteh, Keikawus, Jaeger, Hans, Khuong-Josses, Marie-Aude, Montes-Ramírez, Maria Luisa, Stellbrink, Hans-Jürgen, Yazdanpanah, Yazdan, Richmond, Gary J, Sutton, Kenneth C, Zhang, Feifan, McCoig, Cynthia C, St Clair, Marty H, Vandermeulen, Kati, Van Solingen-Ristea, Rodica, Smith, Kimberly Y, Margolis, David A, Spreen, William R

“…Abstract Background In the Long-Acting Antiretroviral Treatment Enabling Trial 2 (LATTE-2) phase 2b study, long-acting (LA) injectable cabotegravir +…”
Get full text

Effects of cattle manure and soil parent material on shallow groundwater quality by Streeter, Matthew T., Schilling, Keith E., Jones, Christopher S., St. Clair, Marty

“…Livestock are a critical agricultural commodity in the Midwestern United States and are directly linked to row crop production. Chemical and manure nutrient…”
Get full text

Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study by Sutton, Kenneth C, De Vente, Jerome, Leblanc, Roger, Dejesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt S, Vandermeulen, Kati, Spreen, William R

“…Abstract Background In the LATTE study, daily oral cabotegravir + rilpivirine demonstrated higher rates of efficacy than efavirenz + 2 nucleoside…”
Get full text

Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial by Margolis, David A, Dr, Brinson, Cynthia C, MD, Smith, Graham H R, MD, de Vente, Jerome, MD, Hagins, Debbie P, MD, Eron, Joseph J, Prof, Griffith, Sandy K, PharmD, Clair, Marty H St, BS, Stevens, Marita C, MD, Williams, Peter E, PhD, Ford, Susan L, PharmD, Stancil, Britt S, BS, Bomar, Melinda M, BS, Hudson, Krischan J, PhD, Smith, Kimberly Y, MD, Spreen, William R, PharmD

“…Summary Background In phase 1 trials, the HIV-1 integrase strand transfer inhibitor cabotegravir (GSK1265744) was well tolerated, both alone, and in…”
Get full text

Aquifer lithology affects shallow groundwater quality more than nitrogen fertilizer form and placement method in an Iowa agricultural field by Schilling, Keith E., Streeter, Matthew T., Slater, Brennan, Vogelgesang, Jason, Clair, Marty St, Martin, Anthony

“…Excessive nutrient loss threatens local and regional water resources, and many midwestern U.S. states are adopting nutrient reduction strategies to reduce…”
Get full text

Safety and Efficacy of GSK2248761, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive HIV-1-Infected Subjects by Zala, Carlos, St. Clair, Marty, Dudas, Kathleen, Kim, Joseph, Lou, Yu, White, Scott, Piscitelli, Steve, Dumont, Etienne, Pietropaolo, Keith, Zhou, Xiao-Jian, Mayers, Douglas

“…GSK2248761 is a novel, once-daily (QD), next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI) with activity against efavirenz-resistant…”
Get full text

Limited immune restoration after 3 years' suppression of HIV-1 replication in patients with moderately advanced disease by VALDEZ, Hernan, CONNICK, Elizabeth, BLANCHARD-VARGAS, Michelle, LANDAY, Alan, SMITH, Kimberly Y, LEDERMAN, Michael M, BOSCH, Ronald J, KIM, Ryung S, CLAIR, Marty St, KURITZKES, Daniel R, KESSLER, Harold, FOX, Lawrence

“…To describe the magnitude of immune restoration after long-term control of HIV-1 replication. DESIGN Prospective study of immune restoration in patients…”
Get full text

Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor by FERRIS, Robert G, HAZEN, Richard J, SHORT, Steven A, WEAVER, Kurt L, SELLESETH, Dean W, MONIRI, Kelly R, BOONE, Lawrence R, ROBERTS, Grace B, CLAIR, Marty H. St, CHAN, Joseph H, ROMINES, Karen R, FREEMAN, George A, TIDWELL, Jeffrey H, SCHALLER, Lee T, COWAN, Jill R

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals and against a Panel of Protease Inhibitor-Resistant HIV by HAZEN, Richard, HARVEY, Robert, FURFINE, Eric, SPALTENSTEIN, Andrew, HALE, Michael, TUNG, Roger, CLAIR, Marty St, HANLON, Mary, BOONE, Lawrence, FERRIS, Robert, CRAIG, Charles, YATES, Phillip, GRIFFIN, Philip, MILLER, John, KALDOR, Istvan, RAY, John, SAMANO, Vincente

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083 by Marzinke, Mark A, Grinsztejn, Beatriz, Fogel, Jessica M, Piwowar-Manning, Estelle, Li, Maoji, Weng, Lei, McCauley, Marybeth, Cummings, Vanessa, Ahmed, Shahnaz, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Adeyeye, Adeola, Kofron, Ryan, Rinehart, Alex, St Clair, Marty, Rooney, James F, Pryluka, Daniel, Coelho, Lara, Gaur, Aditya, Middelkoop, Keren, Phanuphak, Nittaya, Cohen, Myron S, Hendrix, Craig W, Anderson, Peter, Hanscom, Brett, Donnell, Deborah, Landovitz, Raphael J, Eshleman, Susan H

“…Abstract Background The HIV Prevention Trials Network (HPTN) 083 trial demonstrated that long-acting cabotegravir (CAB-LA) was more effective than tenofovir…”
Get full text

Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study by Stellbrink, Hans-Jürgen, Reynes, Jacques, Lazzarin, Adriano, Voronin, Eugene, Pulido, Federico, Felizarta, Franco, Almond, Steve, Clair, Marty St, Flack, Nancy, Min, Sherene

“…OBJECTIVE:To evaluate the efficacy and safety/tolerability of dolutegravir (DTG, S/GSK1349572), a potent inhibitor of HIV integrase, through the full 96 weeks…”
Get full text

Dissolved phosphate concentrations in Iowa shallow groundwater by Schilling, Keith E., Jacobson, Peter J., St. Clair, Marty, Jones, Christopher S.

“…Regional groundwater phosphorus (P) concentrations are rarely reported, and it is important to develop a better understanding of background concentrations in…”
Get full text

Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084 by Eshleman, Susan H, Fogel, Jessica M, Piwowar-Manning, Estelle, Chau, Gordon, Cummings, Vanessa, Agyei, Yaw, Richardson, Paul, Sullivan, Philip, Haines, Casey D, Bushman, Lane R, Petropoulos, Christos, Persaud, Deborah, Kofron, Ryan, Hendrix, Craig W, Anderson, Peter L, Farrior, Jennifer, Mellors, John, Adeyeye, Adeola, Rinehart, Alex, St Clair, Marty, Ford, Susan, Rooney, James F, Mathew, Carrie-Anne, Hunidzarira, Portia, Spooner, Elizabeth, Mpendo, Juliet, Nair, Gonasagrie, Cohen, Myron S, Hughes, James P, Hosseinipour, Mina, Hanscom, Brett, Delany-Moretlwe, Sinead, Marzinke, Mark A

“…Abstract Background HIV Prevention Trials Network 084 demonstrated that long-acting injectable cabotegravir (CAB) was superior to daily oral tenofovir (TFV)…”
Get full text

Anti-Human Immunodeficiency Virus Type 1 Activity of the Nonnucleoside Reverse Transcriptase Inhibitor GW678248 in Combination with Other Antiretrovirals against Clinical Isolate Viruses and In Vitro Selection for Resistance by HAZEN, Richard J, HARVEY, Robert J, CHAN, Joseph H, BOONE, Lawrence R, CLAIR, Marty H. St, FERRIS, Robert G, FREEMAN, George A, TIDWELL, Jeffrey H, SCHALLER, Lee T, COWAN, Jill R, SHORT, Steven A, ROMINES, Karen R

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text